Anti-DDR1 mAb Combined with PD-1 Blockade Enhances Gastric Cancer Immunotherapy by Activating CD8 T Cells and Suppressing the Col1-DDR1-ERK Pathway.(A21020-)
Anti-DDR1 mAb Combined with PD-1 Blockade Enhances Gastric Cancer Immunotherapy by Activating CD8 T Cells and Suppressing the Col1-DDR1-ERK Pathway.(A21020-)
